[Expression and clinical significance of CD3, CD4 and COX-2 in non-small cell lung cancer]

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2012 Apr;28(4):407-9.
[Article in Chinese]

Abstract

Aim: To study expression and clinical significance of CD3, CD4 and COX-2 in non-small cell lung cancer (NSCLC).

Methods: Expression of COX-2, CD3 and CD4 was detected by immunohistochemical staining in 37 cases of NSCLC. The correlation of CD3, CD4, COX-2 expressions and overall survival(OS) was evaluated with spearman rank correlation analysis.

Results: The average surface density of CD3 and the average optical density of CD4 were significantly associated with OS of NSCLC patients after surgery (P<0.05). However, both two densities of COX-2 were correlated with survival time of patients (P>0.05).

Conclusion: The expressions of CD3, CD4 were significantly associated with OS of NSCLC patients.

MeSH terms

  • Adult
  • Aged
  • CD3 Complex / biosynthesis*
  • CD4 Antigens / biosynthesis*
  • Carcinoma, Non-Small-Cell Lung / metabolism*
  • Carcinoma, Non-Small-Cell Lung / pathology
  • Carcinoma, Non-Small-Cell Lung / surgery
  • Cyclooxygenase 2 / biosynthesis*
  • Female
  • Humans
  • Immunohistochemistry
  • Lung Neoplasms / metabolism*
  • Lung Neoplasms / pathology
  • Lung Neoplasms / surgery
  • Lymphatic Metastasis
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Prognosis
  • Survival Analysis

Substances

  • CD3 Complex
  • CD4 Antigens
  • Cyclooxygenase 2
  • PTGS2 protein, human